VJHemOnc is committed to improving our service to you

IMW 2019 | Predicting risk of fracture in MGUS patients

VJHemOnc is committed to improving our service to you

Jad Sfeir

Dr Jad Sfeir MD, of the Mayo Clinic College of Medicine, Rochester, MN, discusses the significance of monoclonal gammopathy of undetermined significance (MGUS), and why improved clinical availability of measures of bone micro-architecture would be invaluable in the better estimation of fracture risk. Discussed at the International Myeloma Workshop (IMW) 2019, in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter